Quick Answer
Cogent Biosciences, Inc. reported Shares Outstanding of 160.98 million shares for fiscal year 2025.
Cogent Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 160.98M | +45.7% |
| 2024 | 110.46M | +28.3% |
| 2023 | 86.12M | +23.2% |
| 2022 | 69.89M | +59.6% |
| 2021 | 43.81M | +35.4% |
| 2020 | 32.35M | +322.0% |
| 2019 | 7.67M | -74.5% |
| 2018 | 30.06M | +194.6% |
| 2017 | 10.20M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 139.83M | +26.6% | +22.7% |
| June 30, 2025 | 113.93M | +4.2% | +0.1% |
| March 31, 2025 | 113.86M | +19.1% | +3.1% |
| December 31, 2024 | 110.46M | +28.3% | +0.0% |
| September 30, 2024 | 110.46M | +28.3% | +1.0% |
| June 30, 2024 | 109.34M | +28.1% | +14.4% |
| March 31, 2024 | 95.61M | +34.8% | +11.0% |
| December 31, 2023 | 86.12M | +23.2% | +0.0% |
- Cogent Biosciences, Inc. showed an increase of +45.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Cogent Biosciences, Inc.’s shares outstanding has grown by 1478.0% (from 10.20 million shares to 160.98 million shares).
- The most recent figure is from Cogent Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: